Screener
Haemonetics HAE Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Net revenues | $339,380 | $321,394 |
| Cost of goods sold | 136,577 | 129,150 |
| Gross profit | 202,803 | 192,244 |
| Operating expenses: | ||
| Research and development | 16,200 | 16,261 |
| Selling, general and administrative | 118,941 | 110,719 |
| Amortization of acquired intangible assets | 10,204 | 11,392 |
| Total operating expenses | 145,345 | 138,372 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's total cost of revenue?
- Haemonetics (HAE) reported total cost of revenue of $136.58M in Q2 2026.
- How has Haemonetics's total cost of revenue changed year-over-year?
- Haemonetics's total cost of revenue increased by 5.8% year-over-year, from $129.15M to $136.58M.
- What is the long-term trend for Haemonetics's total cost of revenue?
- Over 4 years (2022 to 2026), Haemonetics's total cost of revenue has grown at a 2.9% compound annual growth rate (CAGR), from $487.69M to $546.44M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Haemonetics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude